EVISA Glossary on | Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Drug Testing and Analysis


 

Status
active
Indexing
CAS: Chemical Abstracts Service (ACS); Embase (Elsevier); Focus On: Sports Science & Medicine (Thomson Reuters); MEDLINE (NLM); Science Citation Index Expanded (Thomson Reuters); SCOPUS (Elsevier); Web of Knowledge (Thomson Reuters); Web of Science (Thomson Reuters);
Subject

Source type
Journal
Publisher
ISBN ISSN
1942-7611
First volume
1
Last volume
4+
Homepage
Description

As the incidence of drugs escalates in 21st century living, their detection and analysis have become increasingly important. Sport, the workplace, crime investigation, homeland security, the pharmaceutical industry and the environment are just some of the high profile arenas in which analytical testing has provided an important investigative tool for uncovering the presence of extraneous substances.

In addition to the usual publishing fare of primary research articles, case reports and letters, Drug Testing and Analysis offers a unique combination of; ‘How to’ material such as ‘Tutorials’ and ‘Reviews’, Speculative pieces (‘Commentaries’ and ‘Perspectives', providing a broader scientific and social context to the aspects of analytical testing), ‘Annual banned substance reviews’ (delivering a critical evaluation of the methods used in the characterization of established and newly outlawed compounds).

Rather than focus on the application of a single technique, Drug Testing and Analysis employs a unique multidisciplinary approach to the field of controversial compound determination. Papers discussing chromatography, mass spectrometry, immunological approaches, 1D/2D gel electrophoresis, to name just a few select methods, are welcomed where their application is related to any of the six key topics listed below.

Features and Coverage

The journal will focus on six key topics

  • Sports doping
  • Illicit/recreational drugs use
    e.g. drug-testing methods by employers
  • Pharmaceuticals
    e.g. pharmacokinetics, metabolism studies, characterization and detection of new therapeutics, natural products, biosimilars and generics
  • Toxico-pathology
    e.g. determining posthumous drug presence
  • Forensics/homeland security
    e.g. determining the presence of controlled substances at a crime scene or use by perpetrators, analysis of compounds with potential use as biological or chemical warfare agents
  • Environment
    e.g. wastewater analysis, determination of pollutants/contaminants, etc.


Related links:









Imprint     Disclaimer

© 2003 - 2024 by European Virtual Institute for Speciation Analysis ( EVISA )